Clinical Trials Logo

Clinical Trial Summary

This study aims to evaluate the feasibility to conduct a prospective cohort study evaluating the adverse events associated with manual therapies in children of 5 years and younger. A validated reporting system will be used to evaluate the adverse events and include a total of four questionnaires that are filled online. Adverse events will be evaluated immediately following the intervention and at 48h post-intervention.


Clinical Trial Description

The aim of this study is to investigate (1) the feasibility to conduct a prospective cohort study evaluating the adverse events associated with manual therapies in children of 5 years and younger and (2) to report preliminary data on the frequency and nature of the adverse events. Participating chiropractors will advertise the study in their private clinic through flyers and posters. Legal tutors interested to participate will access an information sheet and consent form using a link available on the flyers/posters. Legal tutors of participants will complete three questionnaires, one before the intervention to describe the child (e.g. age, sex, reason(s) to seek care), one immediately following the intervention to report immediate adverse events and one 48h following the intervention to report delayed adverse events. Clinicians will complete one questionnaire immediately following the intervention to describe the manual therapies delivered to the children. All questionnaires will be available online on a secured platform. The intervention will be determined by the clinician according the their evaluation of the child and could include spinal mobilization as well as soft tissue therapies. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05409859
Study type Observational
Source Université du Québec à Trois-Rivières
Contact
Status Completed
Phase
Start date June 1, 2021
Completion date February 28, 2022

See also
  Status Clinical Trial Phase
Recruiting NCT03668639 - Safety and Antiemetic Efficacy of Akynzeo Plus Dexamethasone During Radiotherapy and Concomitant Weekly Cisplatin Phase 2/Phase 3
Completed NCT05232656 - PREventing Adverse Events Post-Discharge Through Proactive Identification, Multidisciplinary Communication, and Technology N/A
Completed NCT03482232 - Consequences of Doing What Should Not be Done in Primary Care
Completed NCT05693051 - Use of Prone Position Ventilation in Danish Patients With COVID-19 Induced Severe ARDS Treated With VV-ECMO
Completed NCT04055363 - Human Milk Oligosaccharides (HMOs) Post-market Study on Infants N/A
Completed NCT05133817 - Prophylactic Norepinephrine Infusion Combined With Colloid Coloading for Postspinal Anesthesia Hypotension N/A
Completed NCT02996201 - Electronic Patient Reporting of Side Effects to Chemotherapy: A Cluster Randomized Controlled Trial N/A
Recruiting NCT05462938 - Conscious Sedation for Transcatheter Aortic Valve Implantation N/A
Completed NCT04562922 - LIFEMEL Efficacy in Preventing Haematopoietic Toxicity in Patients Treated With Chemotherapy Phase 2
Recruiting NCT03740464 - Long-acting G-CSF for Febrile Neutropenia Phase 3
Completed NCT03332433 - High-flow Nasal Cannula Oxygenation Decrease Hypoxia in Gastroscopy Sedated by Propofol N/A
Not yet recruiting NCT04615156 - 18F-2-fluoro-2-deoxy-D-glucose in Positron Emission Tomography Computed Tomography Phase 3
Recruiting NCT03381534 - Safety and Efficacy of Distal Embolic Protection Device in Vertebral Artery Origin Stenting N/A
Completed NCT04570488 - Predicting Favorable Outcomes in Hospitalized Covid-19 Patients
Recruiting NCT05369962 - Adverse Event Prediction in Geriatric Patients in the ED With Ultrasound
Completed NCT05321160 - Comparison of the Sedation Effect of Esketamine and Sevoflurane for Pediatric Ophthalmological Procedure N/A
Withdrawn NCT03673566 - Clinical Evaluation of the "NICU Clinical Decision Support Dashboard" - CHMCO N/A
Completed NCT03745677 - Redesigning Systems to Improve Quality for Hospitalized Patients N/A
Completed NCT04763876 - Intramuscular Ketorolac at Two Single-Dose Regimens Phase 4
Withdrawn NCT03673579 - Clinical Evaluation of the "NICU Clinical Decision Support Dashboard" - MHSB N/A